SEC Form 4 · accession 0001209191-16-154889
MELINTA THERAPEUTICS, INC. /NEW/ · MLNT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David Zaccardelli
Officer — Acting Chief Executive Officer · Director
Period of report
Dec 9, 2016
Accepted (ET)
Dec 13, 2016 · 4:07 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001461993
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1,F2 | — | Dec 9, 2016 | A | 50,000 | A | — | — | Common Stock | 50,000 | 50,000 | D |
| Stock Option (Right to Buy)F3 | $7.70 | Dec 9, 2016 | A | 150,000 | A | — | Dec 9, 2026 | Common Stock | 150,000 | 150,000 | D |
| Stock Option (Right to Buy)F4 | $22.77 | holding | — | — | — | — | Aug 10, 2026 | Common Stock | 25,000 | 25,000 | D |
Explanation of responses
- F1Each restricted stock unit represents a contingent right to receive one share of Cempra, Inc. common stock.
- F2The restricted stock units vest in full on December 9, 2017, subject to continued employment or Board service.
- F3The option vests on the following schedule: 1/12th of the shares vest monthly at the end of each month over 12 months, beginning after 12/09/2016, subject to continued employment or Board service.
- F4The option vests on the following schedule: 1/12th of the shares vest monthly at the end of each month over 12 months, beginning after 8/10/2016.